DC Advisory: Medtech piques private equity interest

Regulatory stability, an abundance of dry powder and a strong pipeline of assets make medtech a compelling place to put capital to work, says DC Advisory’s Manish Gupta.

SponsoredNorth AmericaWestern EuropeHealthcareTMTRegulationSponsored